CogniCurrent Icon

COGNICURRENT

A compact global news feed for the bigger picture.

⌕
Regions
Topics
Saved views:
Save your current filters to revisit or share.
1 stories
🇧🇷 Folha (PT)
National & Local

Anvisa approves medication that can delay the onset of type 1 diabetes

Anvisa has approved teplizumab, a medication that can potentially postpone the onset of type 1 diabetes for patients aged 8 and older in Brazil.

Mar 11 • 01:09 UTC

Story in context

Loading Intelligence...

📡

Select a report from the feed to view analysis and related coverage.